CRISPR Therapeutics (CRSP) Presents at AACR 2023 - Slideshow

Jon Terrett Session Type: Drug Development Special Track Session Session Title: New Drugs on the Horizon: Part 1 Employee of: CRISPR Therapeutics Stockholder in: CRISPR Therapeutics CRISPR THERAPEUTICS® standard character mark and design logo, CTX001™, CTX110®, CTX112™, CTX121™, CTX130™, CTX131™, CTX310™, CTX320™, CTX330™, COBALT™, VCTX210™, VCTX211™ and VCTX212™ are trademarks and registered trademarks of CRISPR Therapeutics AG. All other trademarks and registered trademarks are the property oftheir respec ...